These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11810596

  • 1. Antimicrobial activity of everninomicin against clinical isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. tested by Etest.
    Terakubo S, Takemura H, Yamamoto H, Ikejima H, Kunishima H, Kanemitsu K, Kaku M, Shimada J.
    J Infect Chemother; 2001 Dec; 7(4):263-6. PubMed ID: 11810596
    [Abstract] [Full Text] [Related]

  • 2. Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity.
    Nakashio S, Iwasawa H, Dun FY, Kanemitsu K, Shimada J.
    Drugs Exp Clin Res; 1995 Dec; 21(1):7-16. PubMed ID: 7796712
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci.
    Hope R, Chaudhry A, Adkin R, Livermore DM.
    Int J Antimicrob Agents; 2013 Mar; 41(3):213-7. PubMed ID: 23298432
    [Abstract] [Full Text] [Related]

  • 4. Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.
    Karlowsky JA, Nichol K, Zhanel GG.
    Clin Infect Dis; 2015 Sep 15; 61 Suppl 2():S58-68. PubMed ID: 26316559
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug 15; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 6. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC, Ribou G, Masquelier B.
    Pathol Biol (Paris); 1992 May 15; 40(5):461-5. PubMed ID: 1386667
    [Abstract] [Full Text] [Related]

  • 7. In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial.
    Jones RN, Hare RS, Sabatelli FJ, Ziracin Susceptibility Testing Group.
    J Antimicrob Chemother; 2001 Jan 15; 47(1):15-25. PubMed ID: 11152427
    [Abstract] [Full Text] [Related]

  • 8. Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates.
    Schouten MA, Hoogkamp-Korstanje JA.
    J Antimicrob Chemother; 1997 Aug 15; 40(2):213-9. PubMed ID: 9301986
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
    MacGowan AP, Noel AR, Tomaselli S, Elliott HC, Bowker KE.
    Antimicrob Agents Chemother; 2011 Feb 15; 55(2):867-73. PubMed ID: 21078943
    [Abstract] [Full Text] [Related]

  • 11. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].
    Yamaguchi T, Yoshida I, Itoh Y, Tachibana M, Takahashi C, Kaku M, Kanemitsu K, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Baba H, Matsuo S, Asari S, Toyokawa M, Matsuoka K, Kusano N, Nose M, Murase M, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y.
    Jpn J Antibiot; 2010 Dec 15; 63(6):431-56. PubMed ID: 21425596
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
    Biedenbach DJ, Arhin FF, Moeck G, Lynch TF, Sahm DF.
    Int J Antimicrob Agents; 2015 Dec 15; 46(6):674-81. PubMed ID: 26541881
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
    Machka K, Braveny I.
    Eur J Clin Microbiol; 1987 Feb 15; 6(1):96-9. PubMed ID: 3032613
    [Abstract] [Full Text] [Related]

  • 14. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC.
    Drugs; 1997 Feb 15; 54 Suppl 6():11-20. PubMed ID: 9474477
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of the new glycopeptide decaplanin.
    Neu HC, Chin NX, Niu WW.
    Eur J Clin Microbiol Infect Dis; 1992 May 15; 11(5):458-62. PubMed ID: 1330562
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the in vitro activity of tigecycline against multiresistant Gram-positive cocci containing tetracycline resistance determinants.
    Borbone S, Lupo A, Mezzatesta ML, Campanile F, Santagati M, Stefani S.
    Int J Antimicrob Agents; 2008 Mar 15; 31(3):209-15. PubMed ID: 17646087
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.
    Dugourd D, Yang H, Elliott M, Siu R, Clement JJ, Straus SK, Hancock RE, Rubinchik E.
    Antimicrob Agents Chemother; 2011 Aug 15; 55(8):3720-8. PubMed ID: 21576435
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods.
    Tubau F, Fernández-Roblas R, Liñares J, Martín R, Soriano F.
    J Antimicrob Chemother; 2001 May 15; 47(5):675-80. PubMed ID: 11328783
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group.
    Marshall SA, Jones RN, Erwin ME.
    Diagn Microbiol Infect Dis; 1999 Jan 15; 33(1):19-25. PubMed ID: 9990471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.